サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：人工授精の世界市場 (2017～2027年)：技術・コンポーネント・供給元・エンドユーザー・企業・地域別の産業規模・シェア・動向・機会・予測
市場調査レポート
商品コード
1152245

人工授精の世界市場 (2017～2027年)：技術・コンポーネント・供給元・エンドユーザー・企業・地域別の産業規模・シェア・動向・機会・予測

Artificial Insemination Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Technique, By Component, By Source, By End User, By Company, By Region
出版日: | 発行: TechSci Research | ページ情報: 英文 114 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.11円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

人工授精の世界市場 (2017～2027年)：技術・コンポーネント・供給元・エンドユーザー・企業・地域別の産業規模・シェア・動向・機会・予測
出版日: 2022年11月01日
発行: TechSci Research
ページ情報: 英文 114 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の人工授精の市場は、2027年にかけての予測期間中に目覚ましい成長を示すと予測されています。

不妊率の上昇と政府の有利な取り組みが同市場の成長を後押ししています。さらに、継続的な技術の進歩と人工授精に関する認知度の向上も、2027年までの市場成長に大きな影響を与えると予測されています。

当レポートでは、世界の人工授精の市場を調査し、市場概要、市場規模および市場シェアの推移・予測、各種区分・地域/主要国別の詳細分析、市場への各種影響因子の分析、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の人工授精市場に対するCOVID-19の影響

第5章 VOC (顧客の声)

第6章 世界の人工授精市場の見通し

  • 市場規模・予測
  • 市場シェア・予測
    • 技術別 (子宮内・子宮頸管内・膣内・卵管内)
    • コンポーネント別 (授精キット・家庭用受胎デバイス・その他)
    • 供給元別 (AIH・AID)
    • エンドユーザー別 (病院・不妊治療クリニック&センター・その他)
    • 企業別
    • 地域別
  • 製品市場マップ

第7章 北米の人工授精市場の見通し

  • 市場規模・予測
  • 市場シェア・予測
    • 技術別
    • コンポーネント別
    • 供給元別
    • エンドユーザー別
    • 国別
  • 国別分析

第8章 欧州の人工授精市場の見通し

  • 市場規模・予測
  • 市場シェア・予測
    • 技術別
    • コンポーネント別
    • 供給元別
    • エンドユーザー別
    • 国別
  • 国別分析

第9章 アジア太平洋の人工授精市場の見通し

  • 市場規模・予測
  • 市場シェア・予測
    • 技術別
    • コンポーネント別
    • 供給元別
    • エンドユーザー別
    • 国別
  • 国別分析

第10章 南米の人工授精市場の見通し

  • 市場規模・予測
  • 市場シェア・予測
    • 技術別
    • コンポーネント別
    • 供給元別
    • エンドユーザー別
    • 国別
  • 国別分析

第11章 中東およびアフリカの人工授精市場の見通し

  • 市場規模・予測
  • 市場シェア・予測
    • 技術別
    • コンポーネント別
    • 供給元別
    • エンドユーザー別
    • 国別
  • 国別分析

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場動向・市場展開

第14章 競合情勢

  • Rocket Medical plc
  • Kitazato Corporation
  • Vitrolife AB
  • Genea Limited
  • Rinovum Women's Health, LLC
  • Pride Angel Limited
  • FUJIFILM Irvine Scientific, Inc.
  • Conceivex, Inc.
  • Surelife Pte Ltd.
  • Biogenics Inc.

第15章 戦略的提言

目次
Product Code: 12862

The global artificial insemination market is grow at impressive rate through 2027. The Medical practitioners practice artificial insemination fertilization method for placing the sperm directly into a female's cervix, fallopian tube, or uterus. These practices are performed on couples or patient-facing fertility issues to achieve pregnancy, as the chances are very high. Due to technological advancement, each step is observed very minutely to reduce the chances of any complication that make this process safer for both mother and baby. According to the UN reports in 2017, the total fertility rate is predicted to decline up to 2.39 (children per woman) between the years 2020 and 2030.

Increasing infertility rate and favorable government initiatives are driving the growth of the market. Furthermore, ongoing technical advancements and increasing awareness about artificial insemination are other factors that are expected to significantly influence the growth of the market through 2027.

Increasing Infertility Rate is Driving the Market Growth

People are facing different problems and issues due to changes in the daily lifestyle of people in the modern world. It includes the food, sleep cycle, physical activities, and mental health, like stress, anxiety, and other problems. The increasing pervasiveness of the problem, consumption of unclean foods, alcohol, tobacco, and diseases like endometriosis, sterilization, cervical mucus problem, and other factors responsible for infertility led to the growth of the Artificial Insemination Market. Family planning and marriages after the 30s increased medical treatment demand for curing infertility. According to the WHO, almost 48 million couples and 186 million individuals have infertility worldwide, accounts 15% of the population. Thus, the above data indicate a positive increase in the market growth of the artificial insemination market in the upcoming year. Many insurance companies are accepting artificial insemination under medical coverage. These initiatives are helping the patient to fight infertility and driving the growth in Artificial Insemination Market.

Peoples are the main asset for any country that can participate and support countries in economic development and growth. Hence, governments are launching various schemes to make their medical infrastructure better and broadly available to meet global benchmarks. The government and international identities make policies and induct new institutions to enhance their medical connectivity, such Assisted Reproductive Technology (ART) Regulation Bill, Nation Public Action Plan, National Family Policy, and other initiatives. As per UNSC, 84% of the country supports the policy that directly and indirectly affects the country's infertility. These policies led to increasing demand for artificial insemination in the market. All the factors mentioned above are expected to drive the growth of the artificial insemination market.

Cost Related with Artificial Insemination is Hindering the Growth

The medical cost for the artificial insemination technique in the USA is between 400 dollars to 4000 dollars approximately. The cost associated with the treatment process is still very costly for many peoples. As it is a medical process, there is a chance of negative pregnancy results after the process is completed. In these cases, patients' losses all their money without any satisfactory result. Many financial institutions are providing medical insurance coverage for artificial insemination. Apart from these supply chain disturbances, the lack of unskilled labor is another factor responsible for restraining market growth.

Increase in Deliberate Collaboration and Product Launch

Growth in market share of the artificial insemination market is propelling the launch of new products and strategic partnerships between two organizations. These scenarios will help both organizations to use their competencies and increase the revenue share. As the market is growing, market players are investing aggressively, leading to technological advancements, and extending their niche market.

In 2021, Vitrolife AB acquired Igenomix S.L to help them extend their product line in existing and target new market segments using their strong competencies.

In 2020, Genea Limited collaborated with Hamilton's throne partner. This step allowed both companies to make good relationships with the customer in USA and Canada and grow the Genea Biomedx operations and customer support.

Market Segmentation

The global artificial insemination market is segmented based on technique, component, source, and end-user. Based on technique, market is divided into intrauterine, intracervical, intravaginal, and intratubal. Based on component type, market is divided into Insemination Kits, Home Conception Devices, and Others. Based on source type, market is split into AIH-Husband, and AID-Donor. Based on end user, market is divided into hospitals, fertility clinics & centers, and others, by company.

Market Players

Rocket Medical plc, Kitazato Corporation, Vitrolife AB, Genea Limited, Rinovum Women's Health, LLC, Pride Angel Limited, FUJIFILM Irvine Scientific, Inc., Conceivex, Inc., Surelife Pte Ltd., Biogenics Incare the major market player in Artificial Insemination Market.

Report Scope:

In this report, global Artificial Insemination Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Artificial Insemination Market, by as technique type:

  • Intrauterine
  • Intracervical
  • Intravaginal
  • Intratubal
  • Others

Artificial Insemination Market, by component type:

  • Insemination Kits
  • Home Conception Devices
  • Others

Artificial Insemination Market, by source type:

  • AIH-Husband
  • AID-Donor

Artificial Insemination Market, by end user type:

  • Hospitals
  • Fertility Clinics & Centers
  • Others

Medical market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global Artificial Insemination Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Artificial Insemination Market

5. Voice of Customer

6. Global Artificial Insemination Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technique (Intrauterine, Intracervical, Intravaginal, Intratubal)
    • 6.2.2. By Component (Insemination Kits, Home Conception Devices, Others)
    • 6.2.3. By Source (AIH-Husband v/s AID-Donor)
    • 6.2.4. By End User (Hospitals, Fertility Clinics & Centers, Others)
    • 6.2.5. By Company (2021)
    • 6.2.6. By Region
  • 6.3. Product Market Map

7. North America Artificial Insemination Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technique
    • 7.2.2. By Component
    • 7.2.3. By Source
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Artificial Insemination Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technique
        • 7.3.1.2.2. By Component
        • 7.3.1.2.3. By Source
        • 7.3.1.2.4. By End User
    • 7.3.2. Mexico Artificial Insemination Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technique
        • 7.3.2.2.2. By Component
        • 7.3.2.2.3. By Source
        • 7.3.2.2.4. By End User
    • 7.3.3. Canada Artificial Insemination Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technique
        • 7.3.3.2.2. By Component
        • 7.3.3.2.3. By Source
        • 7.3.3.2.4. By End User

8. Europe Artificial Insemination Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technique
    • 8.2.2. By Component
    • 8.2.3. By Source
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Artificial Insemination Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technique
        • 8.3.1.2.2. By Component
        • 8.3.1.2.3. By Source
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Artificial Insemination Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technique
        • 8.3.2.2.2. By Component
        • 8.3.2.2.3. By Source
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Artificial Insemination Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technique
        • 8.3.3.2.2. By Component
        • 8.3.3.2.3. By Source
        • 8.3.3.2.4. By End User
    • 8.3.4. Italy Artificial Insemination Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technique
        • 8.3.4.2.2. By Component
        • 8.3.4.2.3. By Source
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Artificial Insemination Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technique
        • 8.3.5.2.2. By Component
        • 8.3.5.2.3. By Source
        • 8.3.5.2.4. By End User

9. Asia-Pacific Artificial Insemination Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technique
    • 9.2.2. By Component
    • 9.2.3. By Source
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Artificial Insemination Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technique
        • 9.3.1.2.2. By Component
        • 9.3.1.2.3. By Source
        • 9.3.1.2.4. By End User
    • 9.3.2. India Artificial Insemination Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technique
        • 9.3.2.2.2. By Component
        • 9.3.2.2.3. By Source
        • 9.3.2.2.4. By End User
    • 9.3.3. South Korea Artificial Insemination Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technique
        • 9.3.3.2.2. By Component
        • 9.3.3.2.3. By Source
        • 9.3.3.2.4. By End User
    • 9.3.4. Japan Artificial Insemination Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Technique
        • 9.3.4.2.2. By Component
        • 9.3.4.2.3. By Source
        • 9.3.4.2.4. By End User
    • 9.3.5. Australia Artificial Insemination Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Technique
        • 9.3.5.2.2. By Component
        • 9.3.5.2.3. By Source
        • 9.3.5.2.4. By End User

10. South America Artificial Insemination Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technique
    • 10.2.2. By Component
    • 10.2.3. By Source
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Artificial Insemination Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technique
        • 10.3.1.2.2. By Component
        • 10.3.1.2.3. By Source
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Artificial Insemination Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technique
        • 10.3.2.2.2. By Component
        • 10.3.2.2.3. By Source
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Artificial Insemination Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technique
        • 10.3.3.2.2. By Component
        • 10.3.3.2.3. By Source
        • 10.3.3.2.4. By End User

11. Middle East and Africa Artificial Insemination Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Technique
    • 11.2.2. By Component
    • 11.2.3. By Source
    • 11.2.4. By End User
    • 11.2.5. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Artificial Insemination Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Technique
        • 11.3.1.2.2. By Component
        • 11.3.1.2.3. By Source
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Artificial Insemination Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Technique
        • 11.3.2.2.2. By Component
        • 11.3.2.2.3. By Source
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Artificial Insemination Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Technique
        • 11.3.3.2.2. By Component
        • 11.3.3.2.3. By Source
        • 11.3.3.2.4. By End User
    • 11.3.4. Egypt Artificial Insemination Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Technique
        • 11.3.4.2.2. By Component
        • 11.3.4.2.3. By Source
        • 11.3.4.2.4. By End User
    • 11.3.5. Turkey Artificial Insemination Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Technique
        • 11.3.5.2.2. By Component
        • 11.3.5.2.3. By Source
        • 11.3.5.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Rocket Medical plc
  • 14.2. Kitazato Corporation
  • 14.3. Vitrolife AB
  • 14.4. Genea Limited
  • 14.5. Rinovum Women's Health, LLC
  • 14.6. Pride Angel Limited
  • 14.7. FUJIFILM Irvine Scientific, Inc.
  • 14.8. Conceivex, Inc.
  • 14.9. Surelife Pte Ltd.
  • 14.10. Biogenics Inc.

15. Strategic Recommendations